Hansoh’s HS-20197 gains NMPA approval for clinical trials
Hansoh Pharmaceutical says its HS-20197 for injection has received clinical trial approval from China’s NMPA.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.